Month: April 2023

Imprivata Launches First Digital Identity Maturity Model and Assessment Developed for Healthcare IT, Security, and Clinical Leadership

Staff April 13, 2023

Free, one-of-a-kind resources deliver actionable guidance to build a comprehensive digital identity strategy that improves care quality, reduces cyber risks,...

Lisa Martinson Joins Vistant as Finance Controller

Staff April 13, 2023

Accounting Leader Brings 30 Years of Government Contracting ExperienceTOWSON, Md., April 13, 2023 (GLOBE NEWSWIRE) -- Vistant, a Maryland-based firm...

Michael Blackton Appointed as Senior Vice President of Elektrofi’s Technical Operations as Elektrofi Continues to Bolster Leadership Bench with Industry Veterans

Staff April 13, 2023

BOSTON, April 13, 2023 (GLOBE NEWSWIRE) -- Today Elektrofi, a biotechnology company focused on drug formulation and delivery innovations, welcomed...

First in Minnesota: Park Nicollet Methodist Hospital Incorporates New State-of-the-Art Breast Cancer Treatment

Staff April 13, 2023

EnVisio Surgical Navigation System and SmartClip Technology Improves Clinical and Cosmetic Outcomes for Breast Cancer Surgery patients EnVisio Surgical Navigation EnVisio...

Sana Biotechnology Announces Preclinical Data Published in Nature Communications Demonstrating the Ability of its Hypoimmune Allogeneic CD19-directed CAR T Cells to Evade Immune Rejection and Produce Durable Anti-Tumor Responses

Staff April 13, 2023

Hypoimmune-modified allogeneic CD19-directed CAR T cells can evade immune detection and kill tumor cells in a novel humanized allogeneic preclinical...

Biomea Fusion Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Staff April 13, 2023

REDWOOD CITY, Calif., April 13, 2023 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or the “Company”) (Nasdaq: BMEA), a clinical-stage...

Neuronetics Announces Continued Momentum for Expanded Health Insurance Coverage for TMS Therapy

Staff April 13, 2023

BlueCross BlueShield of Mississippi Latest to Allow Non-Physician Practitioners to Prescribe TMSMALVERN, Pa., April 13, 2023 (GLOBE NEWSWIRE) -- Neuronetics,...

Hillstream BioPharma Selects OncoBay Clinical to Advance Clinical and Regulatory Development for its Lead Drug Candidate HSB-1216, an Anti-Cancer Mechanism

Staff April 13, 2023

OncoBay Clinical is a boutique clinical research organization (CRO) that is a subsidiary of the Moffitt Cancer Center and has...

SCYNEXIS to Present Ibrexafungerp Data at the 33rd Annual European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) April 15-18 in Denmark

Staff April 13, 2023

JERSEY CITY, N.J., April 13, 2023 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to...

Allogene Therapeutics Announces Participation in Four Upcoming Investor Conferences

Staff April 13, 2023

SOUTH SAN FRANCISCO, Calif., April 13, 2023 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering...

Galecto to Present Two Posters at AACR Annual Meeting 2023

Staff April 13, 2023

BOSTON, April 13, 2023 (GLOBE NEWSWIRE) -- Galecto, Inc. (NASDAQ: GLTO), a clinical-stage biotechnology company and world leader in galectin...

Surgalign Announces Receipt of Nasdaq Deficiency Notice and Intends to Submit Plan to Regain Compliance

Staff April 13, 2023

DEERFIELD, Ill., April 13, 2023 (GLOBE NEWSWIRE) -- Surgalign Holdings, Inc., (NASDAQ: SRGA) a global medical technology company focused on...

SAB Biotherapeutics Granted Fast Track Designation from FDA for SAB-176 Influenza Immunotherapy with High Cross-Reactivity to Multiple Strains of Influenza

Staff April 13, 2023

FDA greenlights advancement of SAB-176 Phase 2b trial and manufacturing approach to address influenza strain change SAB-176 is the first...

Cerevance Announces Poster Presentation at the BNA International Festival of Neuroscience

Staff April 13, 2023

BOSTON, April 13, 2023 (GLOBE NEWSWIRE) -- Cerevance, a private, clinical-stage drug discovery and development company focused on central nervous...

Ascendis Pharma Announces First Quarter 2023 Financial Results and Business Update Conference Call on April 27

Staff April 13, 2023

COPENHAGEN, Denmark, April 13, 2023 (GLOBE NEWSWIRE) -- Ascendis Pharma A/S (Nasdaq: ASND) today announced that the company will hold...

Ocean Biomedical (NASDAQ: OCEA) Announces Notice of Allowance for U.S. Patent Application for Developing “Whole New Class” of Malaria Therapeutics Issued to Scientific Co-founder Dr. Jonathan Kurtis

Staff April 13, 2023

Providence, RI, April 13, 2023 (GLOBE NEWSWIRE) -- Ocean Biomedical, Inc. (NASDAQ: OCEA), a biopharma company working to accelerate the...

Month: April 2023

Imprivata Launches First Digital Identity Maturity Model and Assessment Developed for Healthcare IT, Security, and Clinical Leadership

Lisa Martinson Joins Vistant as Finance Controller

Michael Blackton Appointed as Senior Vice President of Elektrofi’s Technical Operations as Elektrofi Continues to Bolster Leadership Bench with Industry Veterans

First in Minnesota: Park Nicollet Methodist Hospital Incorporates New State-of-the-Art Breast Cancer Treatment

Sana Biotechnology Announces Preclinical Data Published in Nature Communications Demonstrating the Ability of its Hypoimmune Allogeneic CD19-directed CAR T Cells to Evade Immune Rejection and Produce Durable Anti-Tumor Responses

Biomea Fusion Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares

Neuronetics Announces Continued Momentum for Expanded Health Insurance Coverage for TMS Therapy

Hillstream BioPharma Selects OncoBay Clinical to Advance Clinical and Regulatory Development for its Lead Drug Candidate HSB-1216, an Anti-Cancer Mechanism

SCYNEXIS to Present Ibrexafungerp Data at the 33rd Annual European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) April 15-18 in Denmark

Allogene Therapeutics Announces Participation in Four Upcoming Investor Conferences

Galecto to Present Two Posters at AACR Annual Meeting 2023

Surgalign Announces Receipt of Nasdaq Deficiency Notice and Intends to Submit Plan to Regain Compliance

SAB Biotherapeutics Granted Fast Track Designation from FDA for SAB-176 Influenza Immunotherapy with High Cross-Reactivity to Multiple Strains of Influenza

Cerevance Announces Poster Presentation at the BNA International Festival of Neuroscience

Ascendis Pharma Announces First Quarter 2023 Financial Results and Business Update Conference Call on April 27

Ocean Biomedical (NASDAQ: OCEA) Announces Notice of Allowance for U.S. Patent Application for Developing “Whole New Class” of Malaria Therapeutics Issued to Scientific Co-founder Dr. Jonathan Kurtis

Olink to report first quarter 2023 financial results on May 11, 2023

Chinook Therapeutics Announces the Appointment of Robert W. Azelby to its Board of Directors

Revolo Biotherapeutics to Present at the 8th Food Allergy Fund Summit

Solid Biosciences to Present at the 22nd Annual Needham Healthcare Conference

Updated Linvoseltamab Data Showcase Continued Deepening of Responses in Patients with Heavily Pre-Treated Multiple Myeloma

Nurix Therapeutics Presents Positive Results from Ongoing Clinical Trial of NX-5948 in Patients with Relapsed Refractory Chronic Lymphocytic Leukemia (CLL) at the European Hematology Association Congress (EHA2024)

Roche’s Phase III STARGLO study demonstrates Columvi significantly extends survival in people with relapsed or refractory diffuse large B-cell lymphoma

The WISH Clinic Partnering With Clara Care to Bring Specialized Wound Care Directly to Patients in the Convenience of Their Homes

Chinese Team Secures “Best Showpiece Award” at the 52nd UIBC International Competition for Young Bakers with Angel Yeast’s Support

You may have missed